Williams, L., Tay, M. Z., Shen, X., Sawant, S., Dahora, L., Yates, N., … Tomaras, G. (2018). Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 34, pp. 88–88). Madrid, SPAIN: MARY ANN LIEBERT, INC.

Williams, LaTonya, Matthew Zirui Tay, Xiaoying Shen, Sheetal Sawant, Lindsay Dahora, Nicole Yates, David Easterhoff, et al. “Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 34:88–88. MARY ANN LIEBERT, INC, 2018.

Williams L, Tay MZ, Shen X, Sawant S, Dahora L, Yates N, et al. Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 88–88.

Williams, LaTonya, et al. “Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 34, MARY ANN LIEBERT, INC, 2018, pp. 88–88.

Williams L, Tay MZ, Shen X, Sawant S, Dahora L, Yates N, Easterhoff D, Robb M, O’Connell R, Vasan S, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, deCamp A, Phogat S, Sinangil F, Pollara J, Haynes B, Ferrari G, Tomaras G. Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 88–88.